Table 1. Association between SNORD47 expression and clinicopathological features in glioma.
Patients(n=124) | N of cases | Relative SNORD47 expression | P value | |
---|---|---|---|---|
Low | High | |||
Gender | ||||
Male | 80 | 52(65.0%) | 28(35.0%) | 0.879 |
Female | 44 | 28(63.6%) | 16(36.4%) | |
Age(years) | ||||
<55 | 56 | 36(64.3%) | 20(35.7%) | 0.534 |
≥55 | 68 | 40(58.8%) | 28(41.2%) | |
Tumor size(cm) | ||||
<5 | 86 | 48(55.8%) | 38(44.2%) | 0.955 |
≥5 | 38 | 21(55.3%) | 17(44.7%) | |
Tumor Grade | ||||
I/II | 54 | 26(48.1%) | 28(51.9%) | 0.008 |
III/IV | 70 | 50(71.4%) | 20(28.6%) |